Nebulized fentanyl provides subjective improvements for patients with dyspnea [1]

Oncology Nursing Forum

Volumn 32, Issue 1, 2005, Pages 15-

  Schultheis, Christian P ^a  

^a Med Associates Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; NARCOTIC AGENT;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DYSPNEA; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG TUMOR; NEBULIZER; NOTE; PALLIATIVE THERAPY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; DYSPNEA; FENTANYL; HUMANS; LUNG NEOPLASMS; NARCOTICS; NEBULIZERS AND VAPORIZERS; PALLIATIVE CARE; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 33645233366     PISSN: 0190535X     EISSN: 15380688     Source Type: Journal    
DOI: 10.1188/05.ONF.15-16     Document Type: Letter

References (2)

1. Coyne, P., Viswanathan, R., & Smith, T.J. (2001). Fentanyl by nebulizer reduces dyspnea [Abstract 1605a]. Proceedings of the American Society of Clinical Oncology. Retrieved December 2, 2004, from http://www.asco.org/ac/1,1003,_12-002640-00_18-0010-00_19-001605.00.asp
2. Coyne, P.J., Viswanathan, R., & Smith, T.J. (2002). Nebulized fentanyl citrate improves patients' perception of breathing, respiratory rate, and oxygen saturation in dyspnea. Journal of Pain and Symptom Management, 23, 157-160.